Eric Olson

Track

Insider profile

Currently holds a position at Syros Pharmaceuticals Inc

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 18% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Scientific Officer Syros Pharmaceuticals Inc April 1, 2013 -
Eric Olson's trades of Syros Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
202.26
Quantity 6,283
Value US$694,854
Transaction date
Purchase
Price
42.59
Quantity 5,000
Value CHF212,952
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-18 2023-07-17
PlS Planned sale
86,537 +22.8%
178.03
US$865,162 		86,537 +22.8% 178.03 US$865,162
2023-07-17 2023-07-17
PrS Proposed sale
6,283
202.26
US$694,854 		6,283 202.26 US$694,854
2022-01-06 2022-01-05
PlS Planned sale
34,586 -8.9%
50.54
US$2,862,730 		34,586 -8.9% 50.54 US$2,862,730
2021-03-17 2021-03-15
PlS Planned sale
3,628 -100.0%
9.47
US$34,372 		3,628 -100.0% 9.47 US$34,372
2020-08-19 2020-08-18
PlS Planned sale
10,787 -100.0%
13.00
US$140,231 		10,787 -100.0% 13.00 US$140,231
2020-08-19 2020-08-17
PlS Planned sale
4,963 -100.0%
13.00
US$64,519 		4,963 -100.0% 13.00 US$64,519
2020-07-07 2020-07-07
PlS Planned sale
1,753 -100.0%
11.72
US$20,538 		1,753 -100.0% 11.72 US$20,538
2020-02-20 2020-02-18
PlS Planned sale
1,446 -100.0%
7.38
US$10,674 		1,446 -100.0% 7.38 US$10,674
2016-03-26 2016-03-21
B Purchase
5,000
42.59
CHF212,952 		5,000 42.59 CHF212,952